Biopharma Insights
Leqembi, Donanemab and Tofersen: The End of the Journey or the First Step on the Road to Reversing Neurodegeneration?
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem. Read more
16 Aug 2023
R&D revolution: A new paradigm of sourcing and landscaping for the pharma industry
Dr Robin Knight, Co-Founder & Co-CEO of IN-PART, discusses the emerging importance of outsourcing landscaping activities within the pharmaceuticals industry and the benefits of adopting an openly innovative approach that pools sources of innovation. Read more
12 Jul 2023
Enhancing Biotherapeutic Properties with Cell-Line Engineering
Neha Mishra, Ph.D, Senior Scientist Bioproduction at Revvity explores enhancing biotherapeutic properties with cell-line engineering. Read more
30 Jun 2023
Cell line development strategies fit for a new era of Bispecific Antibodies
Nicole Wakes, Senior Director Cell Line Development, and Simon Keen, Vice President Cell Line Development at Abzena, outline the strategies to overcome the challenges of developing BsAbs under increasing pressure for speed. Read more
26 Jun 2023
Science and tech combine to deliver cancer vaccine innovation
Scientific and technological innovation is accelerating the development of effective cancer vaccines, report Drs. Daina Vanags, Cori Gorman and Christian K. Schneider of Biopharma Excellence. Read more
12 Apr 2023
Leveraging RWE early is critical for emerging biopharma companies
Barbara Arone, vice president, real world solutions, IQVIA, examines the ways biotech and emerging biopharma companies can effectively apply real world evidence (RWE) early in the product lifecycle while staying within their resource limits. Read more
3 Mar 2023
ustas7777777/Shutterstock
Pheast presents new preclinical data for anti-CD24 macrophage checkpoint inhibitor
Pheast Therapeutics announced the presentation of new preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage "don't eat me" signal on cancer cells. Read more
12 Nov 2024
Anusorn/Adobe Stock
iotaSciences launches fast single-cell cloning platform for gene therapy
iotaSciences announced the upcoming launch of its newly developed Single-Cell Cloning Platform XT at the Cell 2024 event in London (UK) from November 6-8, 2024. Read more
5 Nov 2024
peterschreiber.media/Adobe Stock
Avantor and NIBRT extend partnership to address biopharma challenges
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex equipment, essential products and expert training to foster innovations in biopharma manufacturing. Read more
24 Oct 2024
Maarten Zeehandelaar/Shutterstock
Signposting the route to sustainable devices with life-cycle assessment
Alex Fong, insights and sustainability lead, Owen Mumford, addresses the environmental impact of single-use drug delivery devices and emphasises the role of life-cycle assessment (LCA) in sustainable design. Read more
18 Nov 2024
Resilience
Futureproofing medicines manufacturing with virtual solutions
Editor Rebekah Jordan speaks to Ivan Wall, a professor at the University of Birmingham and co-director of the Resilience project, to learn about the advancements the initiative is making in UK medicines manufacturing. Read more
15 Nov 2024
Broughton
Three essential tips for stability partner selection
Broughton highlights the top three tips in choosing a stability partner and explains how its extensive expertise positions it as a leader in stability testing. Read more
12 Nov 2024
asadykov/Adobe Stock
Trends shaping collaborations in drug development and manufacturing
Given the success of nasal drug-delivery products relies on balancing formulation and device selection, Eric Kaneps at Renaissance Lakewood, LLC explains the importance of partnerships and collaborations drug development and manufacturing. Read more
8 Nov 2024
ARISTA
Biometric ID drives security and efficiency in pharma manufacturing
Paul Shu of ARISTA Corporation, explains how pharma manufacturers are increasingly turning to wearable biometric ID products to securely speed authentication in a hands-free manner. Read more
18 Oct 2024
Viseven
How can you use content to achieve goals beyond the usual scope?
Nataliya Andreychuk, CEO and co-founder of Viseven, explores how to leverage content in pharma beyond traditional marketing goals, highlighting customer education, societal influence, product development and policy impact. Read more
15 Oct 2024
